Weissgerber attended the Medical School of Ludwig-Maximillian University,
Munich, Germany and served an internship at the Teaching Hospital
of Ludwig-Maximillian University and graduated in 1981.
completed a Fellowship in Clinical Pharmacology at the Medical University
of South Carolina in Charleston, including: Training in Basic Research;
Participation in Clinial Trials; Management of Patients in Hypertensive
1982-1985, Dr. Weissgerber served a residency in internal medicine
at Northeastern University, Aultman Hospital in Canton, Ohio.
1985, he began his practice in Orlando, Florida.
H; Weissgerber, P. Clinical use of Heparin and heparinoids, excluding
the treatment of thromboembolism. Heparin Structure, Cellular Function
and Clinical Application. Edited by Norman H. McDuffie, Academic
H.; Weissgerber, P. The inhibition of cancer cell stickiness, a
model for investigation of platelet aggregation inhibitors in
vivo V. The effect of peributol. J. Med. 12:1, 1981.
of Doctoral Thesis: the influence of hemostasis and immunosystem
on tumor growth and metastasis formation, to be published.
H.; Weissgerber, P.; enzman, F. The inhibition of cancer cell stickiness:
A model for investigation of platelet aggregation inhibitors in
vivo VI. Effect of the sulfonyl urea derivatives, Glibenclamide,
Gliclazide and HB 180 as well as the carboxylic acid derivative
Megletinide. Res. Exp. Med. 170; 85-84, 1982.
P. A polyacrylamide agar hydrogel material for the treatment of
burns. Presented at the Eighth Annual Meeting of the Society for
Biomaterials Symposium, Orlando, Florida, April 1982.
H.; Zoltobrocki, M.; Weissgerber, P. The inhibition of cancer cell
stickiness by stomatostatin. Res. Exp. Med. 182, January